Changes in cognitive functions of patients with dementia of the Alzheimer type following long-term administration of donepezil hydrochloride: Relating to changes attributable to differences in apolipoprotein E phenotype

Geriatrics and Gerontology International

Volumn 10, Issue 1, 2010, Pages 25-31

  Kanaya, Kiyoshi ^a   Abe, Shine ^a   Sakai, Minoru ^a   Fujii, Hiroko ^a   Iwamoto, Toshihiko ^a  

^a TOKYO MEDICAL UNIVERSITY   (Japan)

Author keywords

Apolipoprotein E4; Dementia of Alzheimer type; Long term prognosis risk factor for exacerbation

Indexed keywords

APOLIPOPROTEIN E4; DONEPEZIL;

AGED; ALZHEIMER DISEASE; ARTICLE; CLINICAL ARTICLE; COGNITION; CROSS-SECTIONAL STUDY; DEMENTIA; DISEASE COURSE; DISEASE EXACERBATION; DRUG DOSE INCREASE; FEMALE; HUMAN; LONG TERM CARE; MALE; MINI MENTAL STATE EXAMINATION; PRIORITY JOURNAL; PROGNOSIS; PROTEIN FUNCTION; RISK FACTOR;

AGED; AGED, 80 AND OVER; ALZHEIMER DISEASE; APOLIPOPROTEINS E; BRIEF PSYCHIATRIC RATING SCALE; COGNITION; CROSS-SECTIONAL STUDIES; DISEASE PROGRESSION; HUMANS; INDANS; LONGITUDINAL STUDIES; MALE; NEUROPSYCHOLOGICAL TESTS; NOOTROPIC AGENTS; PHENOTYPE; PIPERIDINES; PROGNOSIS; RETROSPECTIVE STUDIES; TREATMENT OUTCOME;

EID: 73049112555     PISSN: 14441586     EISSN: 14470594     Source Type: Journal    
DOI: 10.1111/j.1447-0594.2009.00551.x     Document Type: Article

References (14)

1. Saunders AM, Strittmatter WJ, Schmechel D. Association of apolipoprotein E allele E{open}4 with late-onset familial and sporadic Alzheimer's disease. Neurology 1993, 43:1467-1472.
2. Poirier J, Davignon J, Bouthillier D. Apolipoprotein E polymorphism and Alzheimer's disease. Lancet 1993, 342:697-699.
3. Rebeck GW, Reiter JS, Strickland DK, Hyman BT. Apolipoprotein E in sporadic Alzheimer's disease: allelic variation and receptor interactions. Neuron 1993, 11:575-580.
4. Mayeux R, Stern Y, Ottman R. The apolipoprotein E{open}4 allele in patients with Alzheimer's disease. Ann Neurol 1993, 34:752-754.
5. Strittmatter WJ, Saunders AM, Schmechel D. Apolipoprotein E: high-avidity binding to β-amyloid and increased frequence of type 4 allele in late-onset familiar Alzheimer disease. Proc Natl Acad Sci USA 1993, 90:1977-1981.
6. Tsai M-S, Tangalos EG, Peterson RC. Apolipoprotein E: risk factor for Alzheimer's disease. Am J Hum Genet 1994, 54:643-649.
7. Chartier-Harlin M-C, Parfitt M, Legrain S. Apolipoprotein E, E{open}4 allele as a major risk factor for sporadic early of the 19q13.2 chromosomal region. Hum Mol Genet 1994, 3:569-574.
8. Hendrie HC, Hall KS, Hui S. Apolipoprotein E genotypes and Alzheimer's disease in a community study of elderly African Americans. Ann Neurol 1995, 37:118-120.
9. Kozauer NA, Mielke MM, Chan GK, Rebok GW, Lyketsos CG. Apolipoprotein E genotype and lifetime cognitive decline. Int Psychogeriatr 2008, 20:109-123.
10. Brayne C, Harrington CR, Wischik CM. Apolipoprotein E genotype in the prediction of cognitive decline and dementia in a prospectively studied elderly population. Dementia 1996, 7:169-174.
11. Tomita N, Ootsuki M, Maruyama M, Matsui T. Long-term cognitive benefits of donepezil in Alzheimer's disease: A retrospective comparison between 1994-1999 and 2000-2004. Geriatr Gerontol Int 2007, 7:41-47.
12. Hashimoto M, Yasuda M, Tanimukai S. Apolipoprotein E epsilon 4 and the pattern of regional brain atrophy in Alzheimer's disease. Neurology 2001, 57:1461-1416.
13. Lehtovirta M, Soininen H, Helisalmi S, Mannerma A. Clinical and neuropsychological characteristics in familial and sporadic Alzheimer's disease: relation to apolipoprotein E polymorphism. Neurology 1996, 46:413-419.
14. Hirono N, Hashimoto M, Ishii K, Kazui H, Mori E. One-year change in cerebral glucose metabolism in patients with Alzheimer's disease. J Neuropsychiatry Clin Neurosci 2004, 16:488-492.